Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 80185 in Psoriasis Vulgaris
NCT01188928Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2010
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of AKP01, betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Sep 2010; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT01188928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188928.